Skip to main content
Log in

The EXXERT Study

  • Technologist Corner
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Thomas GS, Cullom SJ, Kitt TM, Feaheny KM, Ananthasubramaniam K, Gropler RJ et al The EXERRT trial - “EXErcise to Regadenoson in Recovery Trial.” A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson alone for myocardial perfusion imaging using a SPECT protocol. J Nucl Card 2017. doi:10.1007/s12350-017-0813-3.

    Google Scholar 

  2. Ahlberg AW, Baghdasarian SB, Athar H, et al Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging. J Nucl Cardiol 2008;15:42-56.

    Article  PubMed  Google Scholar 

  3. Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao S-S. ASNC imaging guidelines for nuclear cardiology procedures: Stress protocols and tracers. J Nucl Cardiol 2009. doi:10.1007/s12350-009-9062-4.

    Google Scholar 

  4. Thomas GS, Thompson RC, Miyamoto MI, et al. The RegEx trial: A randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. J Nucl Cardiol 2009;16:63-72.

    Article  PubMed  Google Scholar 

  5. Kwon DH, Cerqueira MD, Young R, et al Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients. J Nucl Cardiol 2010;17:853-7.

    Article  PubMed  Google Scholar 

  6. Thompson RC, Patil H, Thompson EC et al Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise. J Nucl Cardiol 2013;20:214-21; quiz 22-6.

  7. Parker MW, Morales DC, Slim HB, et al A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: A randomized controlled trial. J Nucl Cardiol 2013;20:185-96.

    Article  PubMed  Google Scholar 

  8. Partington SL, Lanka V, Hainer J, et al Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol 2012;19:970-8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ross MI, Wu E, Wilkins JT, et al Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial. J Nucl Cardiol 2013;20:197-204.

    Article  CAS  PubMed  Google Scholar 

  10. Rywik TM, Zink RC, Gittings NS, Khan AK, Wright JG, O’Connor FC, Fleg JL. Independent prognostic significance of ischemic ST-segment response limited to recovery from treadmill exercise in asymptomatic subjects. Circulation 1998;97:2117-22.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Randall C. Thompson MD, FASNC.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thompson, R.C., Thomas, G.S. The EXXERT Study. J. Nucl. Cardiol. 24, 1800–1802 (2017). https://doi.org/10.1007/s12350-017-0903-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-017-0903-2

Keywords

Navigation